Skip to main content
Dermatology Week Main banner
Back

Emily Ruiz, MD, MPH (she/her/hers)

Director, DFCI High Risk Cancer Clinic
DFCI/Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts

Associate Physician at the Mohs and Dermatologic Surgery Center at Brigham and Women’s Faulkner Hospital, Assistant Professor in Dermatology at Harvard Medical School and Director of the High-Risk Skin Cancer Clinic at Dana Farber/Brigham and Women’s Hospital. Dr. Ruiz received her medical degree from New York University School of Medicine, and Master of Public Health Degree from Harvard School of Public Health. Dr. Ruiz’s primary research interest is cost analyses of skin cancer care. She received a Career Development Award from the Dermatology Foundation and a Cutting-Edge Research Grant from the American Society for Dermatologic Surgery for her study entitled “Skin Cancer Equity and Expenditure Analysis.” Additionally, she is interested in treatment and outcomes of non-melanoma skin cancer. She is also the principal investigator on a clinical study at Brigham and Women’s Hospital that evaluates intraoperative immunohistochemistry staining with p40 antibody during Mohs micrographic surgery for poorly-differentiated cutaneous squamous cell carcinoma. Additionally, she is evaluating outcomes of adnexal carcinomas in a retrospective cohort.

She lives in Boston MA with her husband and her daughters.

Disclosure information not submitted.

Presentation(s):